Gilead Sciences (GILD) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 29.5% | 21.6% | 24.8% | 2.48% | 37.6% | 39.2% | ||
| Changes by years, y/y, % | +29pp | -8pp | +3pp | -22pp | +35pp | +123.4% | |||
Gilead Sciences. ROE, %
Gilead Sciences. ROE, changes, pp
Gilead Sciences (GILD) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 31.1% | 32.1% | 37.7% | 37.6% | 39.2% | 39.2% | |
| Changes by years, y/y, % | +28pp | +26pp | +37pp | +35pp | +8pp | |||
| Changes by quarters, q/q, % | +29pp | +1pp | +6pp | 0pp | +2pp | |||